Biomarkers that reflect tumor cell proliferation, such as p53 or Ki-67 (MIB-1), have been investigated in other studies with controversial results on survival and recurrent outcomes, although some reported Ki-67 as an unfavorable prognostic factor [38,39]. This evidence concerns the gene TP53 and neoplasm.